ProfileGDS4718 / 1569756_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 12% 4% 7% 6% 14% 8% 15% 9% 12% 8% 6% 9% 4% 6% 8% 12% 8% 3% 4% 16% 7% 10% 14% 10% 15% 4% 11% 15% 13% 4% 6% 8% 12% 6% 9% 4% 13% 7% 7% 11% 9% 13% 5% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8064810
GSM549102patient 115, normal, homogenized [OPG study]3.8749712
GSM549104patient 119, normal, homogenized [OPG study]3.495424
GSM549108patient 138, normal, homogenized [OPG study]3.670997
GSM549119patient 077, normal, homogenized [OPG study]3.63146
GSM549133patient 032, cancer, homogenized [OPG study]3.8806614
GSM549139patient 042, cancer, homogenized [OPG study]3.676138
GSM549099patient 107, normal, homogenized [OPG study]3.9595215
GSM549109patient 139, normal, homogenized [OPG study]3.785889
GSM549110patient 046, normal, homogenized [OPG study]3.8564812
GSM549114patient 063, normal, homogenized [OPG study]3.705938
GSM549122patient 082, normal, homogenized [OPG study]3.625116
GSM549134patient 033, cancer, homogenized [OPG study]3.721359
GSM549136patient 036, cancer, homogenized [OPG study]3.521994
GSM549140patient 044, cancer, homogenized [OPG study]3.612876
GSM549111patient 047, normal, homogenized [OPG study]3.699578
GSM549113patient 057, normal, homogenized [OPG study]3.8016412
GSM549132patient 031, cancer, homogenized [OPG study]3.696428
GSM549137patient 038, cancer, homogenized [OPG study]3.485323
GSM549142patient 047, cancer, homogenized [OPG study]3.578024
GSM549100patient 110, normal, homogenized [OPG study]3.9934116
GSM549107patient 135, normal, homogenized [OPG study]3.637837
GSM549115patient 068, normal, homogenized [OPG study]3.7398810
GSM549116patient 072, normal, homogenized [OPG study]3.8994714
GSM549120patient 078, normal, homogenized [OPG study]3.7783710
GSM549131patient 030, cancer, homogenized [OPG study]3.9238615
GSM549118patient 074, normal, homogenized [OPG study]3.565054
GSM549129patient 027, cancer, homogenized [OPG study]3.8459111
GSM549123patient 088, normal, homogenized [OPG study]3.9516515
GSM549124patient 006, cancer, homogenized [OPG study]3.9340113
GSM549126patient 015, cancer, homogenized [OPG study]3.532334
GSM549128patient 025, cancer, homogenized [OPG study]3.583856
GSM549103patient 117, normal, homogenized [OPG study]3.722778
GSM549117patient 073, normal, homogenized [OPG study]3.837612
GSM549138patient 041, cancer, homogenized [OPG study]3.608536
GSM549141patient 045, cancer, homogenized [OPG study]3.687919
GSM549130patient 028, cancer, homogenized [OPG study]3.517434
GSM549101patient 111, normal, homogenized [OPG study]3.8958413
GSM549105patient 128, normal, homogenized [OPG study]3.668287
GSM549106patient 134, normal, homogenized [OPG study]3.630797
GSM549112patient 048, normal, homogenized [OPG study]3.8265411
GSM549125patient 011, cancer, homogenized [OPG study]3.761459
GSM549127patient 024, cancer, homogenized [OPG study]3.8592913
GSM549135patient 035, cancer, homogenized [OPG study]3.548565